Qiagen
IVDÂ company executives noted that the acceptance and acceleration of decentralized care models have increased, enabling more effective testing for many conditions.
In Brief This Week: Qiagen, Ortho Clinical Diagnostics, MicroGen Diagnostics, and More
News items for the in vitro diagnostics industry for the week of Sept. 6, 2021.
Jury Awards ArcherDx, MGH $4.7M in Qiagen Patent Infringement Lawsuit
A federal jury ruled that various Qiagen sample prep products infringe a pair of US patents underlying ArcherDx's anchored multiplex PCR technology.
Qiagen Gets $600K From US DoD to Ramp up COVID-19 Test Kit, Reagent Manufacturing
The funds will be used to expand manufacturing capacity of enzymatic reagents and reagent kits at Qiagen's Beverly, Massachusetts, location.
The firm has obtained CE marking for its automated, sample-to-answer Vidas TB-IGRA test for latent TBÂ and is preparing a submission for FDA clearance.
Jul 29, 2021
Qiagen Q2 Revenues Grow 28 Percent
May 3, 2021
Qiagen Q1 Revenues Jump 52 Percent
Mar 23, 2021